These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
271 related items for PubMed ID: 2509762
41. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease. Batlle J, López-Fernández MF, Fraga EL, Trillo AR, Pérez-Rodríguez MA. Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936 [Abstract] [Full Text] [Related]
43. Development and applications of surface plasmon resonance-based von Willebrand factor-collagen binding assay. Saenko E, Kannicht C, Loster K, Sarafanov A, Khrenov A, Kouiavskaia D, Shima M, Ananyeva N, Schwinn H, Gruber G, Josic D. Anal Biochem; 2002 Mar 15; 302(2):252-62. PubMed ID: 11878805 [Abstract] [Full Text] [Related]
44. Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study. Rumley A, Lowe GD, Sweetnam PM, Yarnell JW, Ford RP. Br J Haematol; 1999 Apr 15; 105(1):110-6. PubMed ID: 10233372 [Abstract] [Full Text] [Related]
49. Heterogeneity of molecular size of factor VIII/von Willebrand factor in von Willbrand's disease. Mikami S, Takahashi Y, Nishino M, Okubo Y, Fukui H. Thromb Haemost; 1981 Jun 30; 45(3):272-5. PubMed ID: 6792740 [Abstract] [Full Text] [Related]
50. A sensitive immunoassay for von Willebrand factor. Benson RE, Catalfamo JL, Brooks M, Dodds WJ. J Immunoassay; 1991 Jun 30; 12(3):371-90. PubMed ID: 1939665 [Abstract] [Full Text] [Related]
51. Immunoaffinity purification of factor VIII. Weinstein RE. Ann Clin Lab Sci; 1989 Jun 30; 19(2):84-91. PubMed ID: 2502062 [Abstract] [Full Text] [Related]
52. An ELISA test for the binding of von Willebrand antigen to collagen. Brown JE, Bosak JO. Thromb Res; 1986 Aug 01; 43(3):303-11. PubMed ID: 3090735 [Abstract] [Full Text] [Related]
53. Characteristics of the von Willebrand factor in virus inactivated F VIII concentrates: the impact of heat treatment. Ingerslev J, Bukh A, Wallevik K, Møller NP, Stenbjerg S. Thromb Res; 1987 Jul 15; 47(2):175-82. PubMed ID: 3116714 [Abstract] [Full Text] [Related]
58. Characterization of factor VIII/von Willebrand factor concentrates using a modified method of von Willebrand factor multimer analysis. Metzner HJ, Hermentin P, Cuesta-Linker T, Langner S, Müller HG, Friedebold J. Haemophilia; 1998 Apr 15; 4 Suppl 3():25-32. PubMed ID: 10028315 [Abstract] [Full Text] [Related]
59. Cryoprecipitate and Factor VIII commercial concentrates: in vitro characteristics and in vivo compartmental analysis. Morfini M, Longo G, Matucci M, Vannini S, Messori A, Filimberti E, Duminuco M, Avanzi G, Rossi-Ferrini P. Ric Clin Lab; 1984 Apr 15; 14(4):681-91. PubMed ID: 6441235 [Abstract] [Full Text] [Related]
60. Initial clinical experience with a new pasteurized monoclonal antibody purified factor VIIIC. Smith KJ, Lusher JM, Cohen AR, Salzman P. Semin Hematol; 1990 Apr 15; 27(2 Suppl 2):25-9. PubMed ID: 2128855 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]